A cell culture reactor for the on-line evaluation of radiopharmaceuticals: Evaluation of the lumped constant of FDG in human glioma cells
Noll T (2000)
Journal of Nuclear Medicine 41(3): 556-564.
Zeitschriftenaufsatz
| Veröffentlicht | Englisch
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Einrichtung
Erscheinungsjahr
2000
Zeitschriftentitel
Journal of Nuclear Medicine
Band
41
Ausgabe
3
Seite(n)
556-564
Page URI
https://pub.uni-bielefeld.de/record/2393281
Zitieren
Noll T. A cell culture reactor for the on-line evaluation of radiopharmaceuticals: Evaluation of the lumped constant of FDG in human glioma cells. Journal of Nuclear Medicine. 2000;41(3):556-564.
Noll, T. (2000). A cell culture reactor for the on-line evaluation of radiopharmaceuticals: Evaluation of the lumped constant of FDG in human glioma cells. Journal of Nuclear Medicine, 41(3), 556-564.
Noll, Thomas. 2000. “A cell culture reactor for the on-line evaluation of radiopharmaceuticals: Evaluation of the lumped constant of FDG in human glioma cells”. Journal of Nuclear Medicine 41 (3): 556-564.
Noll, T. (2000). A cell culture reactor for the on-line evaluation of radiopharmaceuticals: Evaluation of the lumped constant of FDG in human glioma cells. Journal of Nuclear Medicine 41, 556-564.
Noll, T., 2000. A cell culture reactor for the on-line evaluation of radiopharmaceuticals: Evaluation of the lumped constant of FDG in human glioma cells. Journal of Nuclear Medicine, 41(3), p 556-564.
T. Noll, “A cell culture reactor for the on-line evaluation of radiopharmaceuticals: Evaluation of the lumped constant of FDG in human glioma cells”, Journal of Nuclear Medicine, vol. 41, 2000, pp. 556-564.
Noll, T.: A cell culture reactor for the on-line evaluation of radiopharmaceuticals: Evaluation of the lumped constant of FDG in human glioma cells. Journal of Nuclear Medicine. 41, 556-564 (2000).
Noll, Thomas. “A cell culture reactor for the on-line evaluation of radiopharmaceuticals: Evaluation of the lumped constant of FDG in human glioma cells”. Journal of Nuclear Medicine 41.3 (2000): 556-564.
Google Scholar